BioNexus Gene Lab Income Statement (2018-2025) | BGLC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	3.45M	3.09M	3.58M	3.25M	3.03M	2.49M	2.58M	2.84M	2.38M	2.57M	2.55M	2.27M	2.38M	1.97M	2.63M	2.52M	2.14M	2.26M	2.54M	0.48M
Cost of Revenue (Quarter)	2.87M	2.62M	2.87M	2.77M	2.67M	2.22M	2.28M	2.50M	2.01M	2.23M	2.20M	-5.84M	0.15M	0.14M	2.30M	6.69M	0.54M	0.61M	2.17M	4.64M
Gross Profit (Quarter)	0.58M	0.47M	0.71M	0.48M	0.36M	0.26M	0.30M	0.34M	0.37M	0.34M	0.35M	0.27M	0.37M	0.29M	0.33M	0.31M	0.34M	0.37M	0.38M	-0.00M
Operating items
Research & Development (Quarter)													0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	0.01M
Selling, General & Administrative (Quarter)	0.30M	0.38M	0.38M	0.18M	0.37M	0.45M	0.42M	0.49M	0.54M	0.81M	3.08M	-1.98M	0.32M	0.56M	0.79M	0.17M	0.39M	0.52M	0.45M	0.18M
Restructuring Costs (Quarter)	0.30M	0.38M	0.16M	0.43M	0.37M	0.45M	0.42M	0.49M	0.54M	0.81M	3.08M	-1.98M	0.32M	0.56M	0.79M	0.17M	0.39M	0.52M	0.45M	0.18M
Other Operating Expenses (Quarter)													-1.29M	-0.37M	0.53M	1.05M	-1.85M	0.14M	0.28M	0.68M
Operating Expenses (Quarter)	0.61M	0.76M	0.55M	0.62M	0.74M	0.91M	0.84M	0.98M	1.07M	1.61M	6.16M	-3.97M	-0.65M	0.76M	2.13M	1.40M	-1.05M	1.19M	1.19M	1.05M
Operating Income (Quarter)	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.12M	-0.05M	-0.27M	-2.53M	0.26M	-0.08M	0.26M	-1.34M	-0.42M	-0.62M	-0.61M	-0.70M	-1.03M
EBIT (Quarter)	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.12M	-0.05M	-0.27M	-2.53M	0.26M	-0.08M	0.26M	-1.34M	-0.42M	-0.62M	-0.61M	-0.70M	-1.03M
Non-operating items
Interest & Investment Income (Quarter)													0.03M	0.05M	0.04M	0.03M	0.02M	0.03M	0.02M	0.01M
Other Non Operating Income (Quarter)	-0.21M	-0.01M	-0.06M	0.04M	-0.07M								0.20M	0.73M	0.47M	0.67M	0.09M	0.21M	0.11M	0.02M
Non Operating Income (Quarter)													0.20M	0.73M	0.47M	0.67M	0.09M	0.21M	0.11M	0.02M
Net income details
EBT (Quarter)	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.13M	-0.05M	-0.28M	-2.53M	0.25M	-0.08M	0.25M	-1.34M	-0.42M	-0.62M	-0.62M	-0.71M	-1.04M
Tax Provisions (Quarter)		0.11M	0.08M	0.08M	0.01M	-0.00M	0.01M	0.03M	-0.02M	0.02M	0.08M	-0.10M	-0.02M	0.06M	0.00M	-0.08M
Profit After Tax (Quarter)	0.34M	0.03M	0.30M	0.09M	0.02M	-0.14M	-0.08M	-0.16M	-0.07M	-0.26M	-2.61M	0.31M	-0.10M	0.20M	-1.35M	-0.35M	-0.62M	-0.62M	-0.71M	-1.04M
Equity Income (Quarter)													0.08M	0.09M	0.07M	-0.17M	0.00M	0.02M		-0.03M
Income from Continuing Operations (Quarter)	0.34M	0.03M	0.30M	0.12M	0.02M	-0.14M	-0.08M	-0.15M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M	-1.04M
Consolidated Net Income (Quarter)	0.34M	0.03M	0.30M	0.12M	0.02M	-0.14M	-0.08M	-0.15M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M	-1.04M
Income towards Parent Company (Quarter)	0.34M	0.03M	0.30M	0.12M	0.02M	-0.14M	-0.08M	-0.15M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M	-1.04M
Net Income towards Common Stockholders (Quarter)	0.34M	0.03M	0.30M	0.12M	0.02M	-0.14M	-0.08M	-0.15M	-0.04M	-0.29M	-2.61M	0.35M	-0.10M	0.20M	-1.35M	-0.35M	-0.62M	-0.62M	-0.71M	-1.04M
Additional items
EPS (Basic) (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01	0.00	-0.02	-0.16	0.02	-0.01	0.01	-0.08	-0.20	-0.35	-0.34	-0.39	-0.56
EPS (Weighted Average and Diluted) (Quarter)												0.02	-0.01	0.11	-0.75	0.61	-0.04	-0.34	-0.40
Shares Outstanding (Weighted Average) (Quarter)	171.22M	171.22M	171.22M	171.22M	171.22M	172.10M	14.48M	14.41M	14.48M	14.48M	16.77M	15.88M	17.67M	17.67M	17.77M	1.78M	1.80M	1.80M	1.80M	1.86M
Shares Outstanding (Diluted Average) (Quarter)												15.88M	17.67M	1.77M	1.78M	17.82M	17.97M	1.80M	1.80M
EBITDA (Quarter)	0.13M	0.02M	0.24M	0.13M	-0.05M	-0.46M	-0.40M	0.24M	-0.11M	-0.59M	-2.63M	0.43M	-0.31M	0.20M	-0.30M	-1.07M	-0.55M	-0.25M	-0.71M	-1.04M
Interest Expenses (Quarter)		0.00M	-0.00M	-0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.00M	0.00M	0.01M	0.00M
Tax Rate (Quarter)		79.30%	20.29%	41.15%	45.59%	1.16%	-15.03%	-20.10%	30.13%	-5.81%	-3.02%	-38.63%	23.98%	21.82%	-0.12%	19.12%

Research Tools

BioNexus Gene Lab Income Statement (2018-2025) | BGLC

Create an account

Sign In

Reset Password